Nyxoah is a pioneering medical technology company specializing in innovative solutions for obstructive sleep apnea (OSA) treatment, primarily through its proprietary Genio system, which utilizes minimally invasive hypoglossal nerve stimulation techniques. Committed to clinical validation and extensive research, Nyxoah aims to significantly improve patient outcomes and quality of life for those suffering from OSA. By focusing on innovation within the sleep medicine sector and forming strategic partnerships, the company is well-positioned to capitalize on the increasing demand for effective…